Clinical trial
Doxycycline in Combination With Sitagliptin on the Glycemic and Cardiac Indices in Patients With Type 2 Diabetes Mellitus
NCT06329882 is registered in ClinicalTrials.gov with Mostafa Bahaa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Doxycycline in Combination With Sitagliptin on the Glycemic and Cardiac Indices in Patients With Type 2 Diabetes Mellitus
- Lead sponsor
- Mostafa Bahaa
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 30, 2024
- Completion date
- March 20, 2026
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.